K. Morita

Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes.

K. Hara, Y. Aso, K. Takebayashi, 2010, Diabetes research and clinical practice.

Comparison of effects of insulin aspart three times a day versus insulin detemir once a day on oxidative stress in patients with type 2 diabetes.

Y. Aso, K. Takebayashi, T. Inukai, 2011, Endocrine journal.

Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients.

K. Hara, Y. Aso, K. Takebayashi, 2015, Obesity research & clinical practice.

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea.

K. Hara, Y. Aso, K. Takebayashi, 2012, Translational research : the journal of laboratory and clinical medicine.

Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction.

K. Hara, Y. Aso, S. Matsumoto, 2009, Translational research : the journal of laboratory and clinical medicine.

Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes.

K. Hara, Y. Aso, K. Takebayashi, 2013, Saudi medical journal.

The effect of insulin therapy and plasma glucose levels on corrected QT intervals in patients with type 2 diabetes

Y. Aso, K. Takebayashi, T. Inukai, 2012 .